Novo Nordisk A S (NONOF) stock

NONOFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVO

Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30

$38.24−0.60 (-1.53%)

Close on Oct 19, 2026Market cap $170.76BP/E 11.1Yield –

Novo Nordisk A S operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2025 it was 41.3%, against 44.2% the year before. The highest annual figure on record is 45.8% in fiscal 2015.

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	41.3%	−2.9
FY2024	Dec 31, 2024	44.2%	+0.0
FY2023	Dec 31, 2023	44.2%	+1.9
FY2022	Dec 31, 2022	42.3%	+0.6
FY2021	Dec 31, 2021	41.7%	−1.0
FY2020	Dec 31, 2020	42.6%	−0.4
FY2019	Dec 31, 2019	43.0%	+0.8
FY2018	Dec 31, 2018	42.2%	−1.6
FY2017	Dec 31, 2017	43.8%	+0.5
FY2016	Dec 31, 2016	43.3%	−2.5
FY2015	Dec 31, 2015	45.8%	–

Parsed from the XBRL in Novo Nordisk A S's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Jan 31, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is NONOF.

Revenue growth6.4% · median 8.9%

Gross margin81.0% · median 69.7%

Advertisement
300 × 250

See a number that looks wrong?